Role of P-glycoprotein (gp170) in T-lymphocyte activation and proliferation.

被引:0
|
作者
Gollapudi, S [1 ]
Kim, CH [1 ]
Gupta, S [1 ]
机构
[1] UNIV CALIF IRVINE,IRVINE,CA 92717
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:843 / 843
页数:1
相关论文
共 50 条
  • [31] Regeneration and tolerance factor is expressed during T-lymphocyte activation and plays a role in apoptosis
    Boomer, JS
    Derks, RA
    Lee, GW
    DuChateau, BK
    Gilman-Sachs, A
    Beaman, KD
    HUMAN IMMUNOLOGY, 2001, 62 (06) : 577 - 588
  • [32] CD101 is expressed by skin dendritic cells - Role in T-lymphocyte activation
    Bagot, M
    Martinel, I
    Charue, D
    Weill, F
    Boulland, ML
    Wechsler, J
    Freeman, GJ
    Bensussan, A
    Boumsell, L
    TISSUE ANTIGENS, 1997, 50 (05): : 439 - 448
  • [33] A Human Lymphocyte Based Ex Vivo Assay to Study the Effect of Drugs on P-glycoprotein (p-Gp) Function1
    Dolly A Parasrampuria
    Marianne V Lantz
    Leslie Z Benet
    Pharmaceutical Research, 2001, 18 : 39 - 44
  • [35] THE ROLE OF RECEPTOR LIGAND ENDOCYTOSIS AND DEGRADATION IN INTERLEUKIN-2 SIGNALING AND T-LYMPHOCYTE PROLIFERATION
    LEGRUE, SJ
    SHEU, TL
    CHERNAJOVSKY, Y
    LYMPHOKINE AND CYTOKINE RESEARCH, 1991, 10 (06): : 431 - 436
  • [36] P-glycoprotein 170 (P-GP) functional activity in peripheral blood lymphocytes (PBL) of IBD patients during treatment with anti-TNFs
    Sambuelli, A.
    Cortada, C.
    Gil, A.
    Negreira, S.
    Bellicoso, M.
    Huernos, S.
    Tirado, P.
    Chavero, P.
    Goncalves, S.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S243 - S244
  • [37] Anti-P-glycoprotein antibody-induced apoptosis of activated peripheral blood lymphocytes: A possible role of P-glycoprotein in lymphocyte survival
    Gollapudi, S
    Gupta, S
    JOURNAL OF CLINICAL IMMUNOLOGY, 2001, 21 (06) : 420 - 430
  • [38] Anti-P-Glycoprotein Antibody-Induced Apoptosis of Activated Peripheral Blood Lymphocytes: A Possible Role of P-Glycoprotein in Lymphocyte Survival
    Sastry Gollapudi
    Sudhir Gupta
    Journal of Clinical Immunology, 2001, 21 : 420 - 430
  • [39] INHIBITION OF T-LYMPHOCYTE ACTIVATION BY A NOVEL P56(LCK) TYROSINE KINASE INHIBITOR
    FALTYNEK, CR
    WANG, S
    MILLER, D
    MAUVAIS, P
    GAUVIN, B
    REID, J
    XIE, W
    HOEKSTRA, S
    JUNIEWICZ, P
    SARUP, J
    LEHR, R
    SAWUTZ, DG
    MURPHY, D
    JOURNAL OF ENZYME INHIBITION, 1995, 9 (02): : 111 - 122
  • [40] Inhibitors of p56lck:: assessing their potential as tools for manipulating T-lymphocyte activation
    Dowden, J
    Ward, SG
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2001, 11 (02) : 295 - 306